ストックスクリーナーアプリを入手
2.39
3.43%
-0.085
前日終値:
$2.475
開ける：
$2.49
24時間の取引高:
751.54K
Relative Volume:
0.93
時価総額：
$160.99M
収益：
$488.00K
当期純損益:
$-41.44M
株価収益率:
-2.5699
EPS:
-0.93
ネットキャッシュフロー:
$-31.47M
1週間 パフォーマンス:
+13.27%
1か月 パフォーマンス:
+6.70%
6か月 パフォーマンス:
-36.94%
1年 パフォーマンス:
-26.91%
1日の値動き範囲:
$2.365
$2.50
1週間の範囲:
$2.11
$2.59
52週間の値動き範囲:
$1.90
$5.6395
Cardiff Oncology Inc Stock (CRDF) Company Profile
名前
Cardiff Oncology Inc
セクター
電話
858-952-7570
住所
11055 FLINTKOTE AVENUE, SAN DIEGO, CA
CRDF を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CRDF
Cardiff Oncology Inc
|
2.39 | 166.72M | 488.00K | -41.44M | -31.47M | -0.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Cardiff Oncology Inc Stock (CRDF) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-08 | 開始されました | Ladenburg Thalmann | Buy |
| 2025-06-24 | 開始されました | Jefferies | Hold |
| 2024-09-06 | 開始されました | Craig Hallum | Buy |
| 2022-01-05 | 開始されました | William Blair | Outperform |
| 2021-12-08 | 開始されました | Robert W. Baird | Outperform |
| 2021-08-09 | 再開されました | Maxim Group | Buy |
| 2020-10-22 | 開始されました | H.C. Wainwright | Buy |
| 2020-10-08 | 開始されました | Piper Sandler | Overweight |
すべてを表示
Cardiff Oncology Inc (CRDF) 最新ニュース
Zacks Small Cap Weighs in on CRDF FY2025 Earnings - Defense World
What drives Cardiff Oncology Inc stock priceSmall Cap Stock Opportunities & Free Daily Stock Hotspot Analysis - earlytimes.in
FY2025 Earnings Forecast for CRDF Issued By Zacks Small Cap - MarketBeat
A new trading data show Cardiff Oncology Inc (CRDF) is showing positive returns. - setenews.com
Institutions profited after Cardiff Oncology, Inc.'s (NASDAQ:CRDF) market cap rose US$19m last week but retail investors profited the most - Yahoo Finance
CRDF: Initiating Coverage – Combination Therapy Elicits Superior Response - Zacks Small Cap Research
Cardiff Presents Phase 1 Data Of Onvensertib In Chronic Myelomonocytic Leukemia At ASH 2025 - Nasdaq
Cardiff oncology reports positive results for onvansertib in leukemia trial - Investing.com
Cardiff oncology reports positive results for onvansertib in leukemia trial By Investing.com - Investing.com India
Cardiff Oncology Announces Clinical Data from Investigator-Sponsored Trial with Onvansertib in Chronic Myelomonocytic Leukemia at ASH 2025 - The Manila Times
Cardiff Oncology Announces Clinical Data from - One News Page
Cardiff Oncology to Present at Sidoti’s Year-End Virtual Investor Conference - The Manila Times
Is Cardiff Oncology Inc. stock a contrarian buy2025 Key Highlights & Technical Pattern Based Signals - Newser
How Cardiff Oncology Inc. (XE7C) stock stacks up against competitorsMarket Risk Report & Low Volatility Stock Recommendations - Newser
Will Cardiff Oncology Inc. (XE7C) stock announce a stock splitAnalyst Upgrade & Technical Pattern Based Signals - Newser
Can Cardiff Oncology Inc. (XE7C) stock stage a strong rebound this quarter2025 Year in Review & High Accuracy Trade Alerts - Newser
How Cardiff Oncology Inc. (XE7C) stock reacts to stronger dollarJuly 2025 Rallies & Long-Term Investment Growth Plans - Newser
Will Cardiff Oncology Inc. stock outperform Dow Jones indexJuly 2025 Trends & Stepwise Trade Signal Guides - Newser
Cardiff Oncology (CRDF) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Is Cardiff Oncology Inc. stock a defensive play in 2025CPI Data & Free Daily Entry Point Trade Alerts - Newser
Is Cardiff Oncology Inc. stock attractive after correctionJuly 2025 Earnings & Real-Time Sentiment Analysis - Newser
It is Poised to be a Bull Market for Cardiff Oncology Inc (CRDF) - setenews.com
Can Cardiff Oncology Inc. stock double in next 5 yearsWall Street Watch & Fast Exit and Entry Strategy Plans - BỘ NỘI VỤ
Quarterly Trades: Will Cardiff Oncology Inc. stock benefit from green energy trendsEarnings Trend Report & Low Risk High Reward Ideas - moha.gov.vn
Cardiff Oncology, Inc. (NASDAQ:CRDF) Receives $10.63 Average Price Target from Analysts - Defense World
AlphaCore Capital LLC Acquires Shares of 101,575 Cardiff Oncology, Inc. $CRDF - Defense World
Cardiff Oncology, Inc. to Participate in Piper Sandler 37th Annual Healthcare Conference - Quiver Quantitative
Cardiff Oncology (NASDAQ: CRDF) to Join Piper Sandler 37th Conference Fireside Chat - Stock Titan
Can Cardiff Oncology Inc. (XE7C) stock hit consensus price targetsJuly 2025 Catalysts & Reliable Entry Point Trade Alerts - newser.com
Is Cardiff Oncology Inc. forming a reversal pattern2025 Technical Patterns & Growth Focused Stock Pick Reports - newser.com
What analysts say about Cardiff Oncology Inc stockFlag and Pennant Patterns & Grow Smarter With Pro-Level Research - earlytimes.in
Painful week for individual investors invested in Cardiff Oncology, Inc. (NASDAQ:CRDF) after 11% drop, institutions also suffered losses - simplywall.st
What does recent volatility data suggest for Cardiff Oncology Inc.Market Trend Review & Fast Exit Strategy with Risk Control - newser.com
Will Cardiff Oncology Inc. (XE7C) stock beat international competitionEarnings Beat & Daily Technical Stock Forecast Reports - newser.com
Can Cardiff Oncology Inc. hit a new high this monthJuly 2025 Patterns & Verified Chart Pattern Trade Signals - newser.com
Will Cardiff Oncology Inc. stock gain from strong economyWeekly Trend Recap & High Accuracy Swing Trade Signals - newser.com
Using Bollinger Bands to evaluate Cardiff Oncology Inc.Entry Point & Verified Short-Term Plans - newser.com
Will Cardiff Oncology Inc. (XE7C) stock draw ESG focused fundsPortfolio Update Summary & Proven Capital Preservation Methods - newser.com
Is Cardiff Oncology Inc. stock a safe investment in uncertain marketsJuly 2025 Momentum & AI Enhanced Execution Alerts - newser.com
Should you hold or exit Cardiff Oncology Inc. now2025 Support & Resistance & Long-Term Growth Stock Strategies - newser.com
Cardiff Oncology Inc (CRDF) 財務データ
収益
当期純利益
現金流量
EPS
Cardiff Oncology Inc (CRDF) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| PACE GARY W | Director |
Jul 30 '25 |
Buy |
2.45 |
15,000 |
36,750 |
1,345,676 |
| Levine James E. | Chief Financial Officer |
Dec 17 '24 |
Buy |
5.42 |
2,752 |
14,905 |
65,316 |
| Levine James E. | Chief Financial Officer |
Dec 18 '24 |
Buy |
5.00 |
2,400 |
12,000 |
67,716 |
| Levine James E. | Chief Financial Officer |
Dec 16 '24 |
Buy |
3.83 |
2,564 |
9,820 |
62,564 |
1.08%
0.91%
大文字化:
|
ボリューム (24 時間):